美股市场个股详情

AEZS 依特钠

添加自选
  • 7.9900
  • +0.1900+2.44%
收盘价 05/06 16:00 (美东)
  • 7.6600
  • -0.3300-4.13%
盘后 16:46 (美东)
969.96万总市值-585市盈率TTM

关于依特钠公司

苩erna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

公司介绍

公司代码AEZS
公司名称依特钠
上市日期2000/05/10
成立日期1990
CEODr. Klaus Paulini
所属市场纳斯达克
员工数量21
证券类型海外普通股
年结日12-31
公司地址315 Sigma Drive,Summerville
城市Charleston
省份南卡罗来纳州
国家美国
邮编29486
电话1-843-900-3223
网址http://www.zentaris.com

董事高管

  • 姓名
  • 职务
  • 年薪
  • Dr. Klaus Paulini
  • Director, President and Chief Executive Officer; Managing Director, AEZS Germany
  • 58.40万
  • Nicola Ammer
  • Chief Medical Officer and Senior Vice President, Clinical Development
  • 16.80万
  • Giuliano La Fratta
  • Senior Vice President and Chief Financial Officer
  • 26.73万
  • Dr. Michael Teifel
  • Senior Vice President, Non Clinical Development and Chief Scientific Officer
  • 3.71万
  • Dr. Matthias Gerlach
  • Senior Vice President, Manufacturing and Supply Chain
  • --
  • Carolyn Egbert
  • Chairman of the Board
  • 17.30万
  • Dennis Turpin
  • Director
  • 15.80万
  • Gilles Gagnon
  • Independent Director
  • 6.25万
  • Peter G. Edwards
  • Independent Director
  • 14.05万

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议
美股
综合热度
股票代码
最新价
涨跌幅